Stock comparison
Insulet
PODD$9.23BHealthcare Market cap, Sector
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$104.46BHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
PODD 07 SANOFICONR.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
PODD0wins
7winsSANOFICONR.BO
55D
B78
81B
A89
72B
B83
56D
B77
46D
A91
58D
A86
59D
A85
Side-by-side metrics
| Metric | PODD | SANOFICONR.BO |
|---|---|---|
| Market cap | $9.23B | $104.46B Winner |
| P/E (TTM) | Winner: 36.2x | 44.0x |
| EV/EBIT | Winner: 23.9x | 31.7x |
| ROIC (TTM) | 16.39% | 59.15% Winner |
| Gross margin | Winner: 71.01% | 68.13% |
| Net margin | 10.44% | 27.35% Winner |
| Revenue CAGR 5y | 25.3% | 27.01% Winner |
| EPS CAGR 5y | Winner: 93.57% | 20.67% |
| Debt / Equity | 0.7x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
PODD leads on
- EPS CAGR 5y93.57%vs 20.67%+78%
- EV/EBIT23.9xvs 31.7x+25%
- P/E (TTM)36.2xvs 44.0x+18%
SANOFICONR.BO leads on
- Market cap$104.46Bvs $9.23B+91%
- Debt / Equity0.1xvs 0.7x+91%
- ROIC (TTM)59.15%vs 16.39%+72%
- Net margin27.35%vs 10.44%+62%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.